Dr Reddy’s Gains on Strong Q4, But Mixed Views Temper Optimism

Dr Reddy’s shares rose 0.79% on May 12 after Q4 profit jumped 22% YoY to ₹1,594 crore. Growth came from new launches and acquisitions. However, falling gross margins and U.S. pricing pressure led to mixed broker ratings, with targets ranging from ₹1,050 to ₹1,575.